Assyro AI

Orange Book product · Brand (NDA)

ZILRETTA

TRIAMCINOLONE ACETONIDE

Brand (NDA)NDA 208845RX PACIRA PHARMS INC

At a glance

Oct 06, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 06, 2017

    8 yr 10 mo ago

  2. Today

  3. Patent 8828440 expires

    Listed drug product patent expiration.

    Aug 04, 2031

    in 5 yr 2 mo

  4. Patent 9555048 expires

    Listed method-of-use patent (U-2151) expiration.

    Aug 04, 2031

    in 5 yr 2 mo

Pharmaceutical detail

Active ingredient

TRIAMCINOLONE ACETONIDE

Strength

32MG/VIAL

Dosage form

FOR SUSPENSION, EXTENDED RELEASE

Route

INTRA-ARTICULAR

TE code

Not listed

Application

NDA 208845

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8828440Aug 04, 2031in 5 yr 2 mo
Product
9555048Aug 04, 2031in 5 yr 2 mo
U-2151
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.